Post by thriving 4m @my69z The March 27
Post# of 153179
4m
@my69z
The March 27 PR by Creatv Microtech also pointed out the PD-L1 marker testing. We really didn't know how important that was until yesterday.
"By tracking CTC and CAML counts, and CAML size at various time points, LifeTracDx® can provide prognostic insights and predict treatment response. CytoDyn is also interested in the expressions of CCR5 and PD-L1 markers on the tumor. These markers can change over time. LifeTracDx® can provide this information by a blood test - no tissue is required. "

